Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Cash & Current Investments: 2011-2012

Historic Cash & Current Investments for Sonoma Pharmaceuticals (SNOA) over the last 2 years, with Mar 2012 value amounting to $3.4 million.

  • Sonoma Pharmaceuticals' Cash & Current Investments rose 33.00% to $6.6 million in Q4 2012 from the same period last year, while for Dec 2012 it was $22.7 million, marking a year-over-year increase of 26.02%. This contributed to the annual value of $3.4 million for FY2012, which is 23.34% down from last year.
  • Sonoma Pharmaceuticals' Cash & Current Investments amounted to $3.4 million in FY2012, which was down 23.34% from $4.4 million recorded in FY2011.
  • In the past 5 years, Sonoma Pharmaceuticals' Cash & Current Investments registered a high of $4.4 million during FY2011, and its lowest value of $3.4 million during FY2012.
  • Its 2-year average for Cash & Current Investments is $3.9 million, with a median of $3.9 million in 2011.
  • Data for Sonoma Pharmaceuticals' Cash & Current Investments shows a maximum YoY fell of 23.34% (in 2012) over the last 5 years.
  • Yearly analysis of 2 years shows Sonoma Pharmaceuticals' Cash & Current Investments stood at $4.4 million in 2011, then fell by 23.34% to $3.4 million in 2012.